清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Chinese Neurosurgical Randomized Controlled Trials: Dynamics in Trial Implementation and Completion

医学 随机对照试验 梅德林 神经外科 科克伦图书馆 大流行 报告审判综合标准 临床试验 2019年冠状病毒病(COVID-19) 重症监护医学 外科 疾病 内科学 政治学 传染病(医学专业) 法学
作者
Tao Liu,Mingqi Liu,Zhuang Sha,Chenrui Wu,Zhihao Zhao,Jiangyuan Yuan,Dongyi Feng,Meng Nie,Rongcai Jiang
出处
期刊:Neurosurgery [Lippincott Williams & Wilkins]
被引量:2
标识
DOI:10.1227/neu.0000000000002702
摘要

BACKGROUND AND OBJECTIVES: The focus on evidence-based neurosurgery has led to a considerable amount of neurosurgical evidence based on randomized controlled trials (RCTs) being published. Nevertheless, there has been no systematic appraisal of China's contribution to RCTs. Information about the changes in characteristics of Chinese neurosurgical RCTs before and during the COVID-19 pandemic is limited. This study aims to perform a detailed examination and comprehensive analysis of the characteristics of Chinese neurosurgical RCTs and to examine the differences before and during the COVID-19 pandemic. METHODS: We conducted a comprehensive database search including PubMed, Web of Science, Embase, and Cochrane Library up to March 2023, with a criterion of inclusion based on an impact factor above 0. We subsequently examined the design and quality parameters of the included RCTs and assessed the differences before and during the COVID-19 pandemic (based on follow-up ending before or after January 2020). Moreover, we investigated potential factors that may affect the quality and developmental trends of neurosurgical RCTs in China. RESULTS: The main focus of the 91 neurosurgical RCTs was vascular disease (47.3%) and trauma (18.7%). Over half of the trials used Consolidated Standards of Reporting Trial diagrams (69.2%), and the majority compared nonsurgical treatments (63.7%). Larger trials tended to have better quality scores, but those with significant efficacy were less likely to have power calculations. Over time, there was an increase in the use of Consolidated Standards of Reporting Trial diagrams and well-specified outcomes. The COVID-19 pandemic may have hindered the completion of neurosurgical RCTs in China, but it has had little impact on the design and quality so far. CONCLUSION: Chinese neurosurgeons have made significant progress in advancing neurosurgical RCTs despite challenges. However, shortcomings in sample size and power calculation need attention. Improving the rigor, rationality, and completeness of neurosurgical RCT design is crucial.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
23秒前
27秒前
榆木小鸟完成签到 ,获得积分10
27秒前
雪流星完成签到 ,获得积分10
55秒前
科研通AI2S应助科研通管家采纳,获得10
1分钟前
1分钟前
蒙面侠完成签到 ,获得积分10
1分钟前
CC发布了新的文献求助10
1分钟前
哈哈哈完成签到 ,获得积分10
1分钟前
王世卉完成签到,获得积分10
1分钟前
ccyy完成签到 ,获得积分10
1分钟前
3120221053完成签到,获得积分10
2分钟前
是玥玥啊完成签到 ,获得积分10
2分钟前
小新小新完成签到 ,获得积分10
2分钟前
Qvby3完成签到 ,获得积分10
2分钟前
英姑应助ceeray23采纳,获得20
2分钟前
imica完成签到 ,获得积分10
2分钟前
bkagyin应助ceeray23采纳,获得20
3分钟前
Ralph完成签到,获得积分10
3分钟前
科研搬运工完成签到,获得积分0
3分钟前
binbinbin发布了新的文献求助20
3分钟前
binbinbin完成签到,获得积分20
3分钟前
cy完成签到,获得积分10
4分钟前
满意的伊完成签到,获得积分10
4分钟前
4分钟前
John完成签到 ,获得积分10
4分钟前
蔡从安完成签到,获得积分20
4分钟前
傲娇而又骄傲完成签到 ,获得积分10
5分钟前
精明晓刚发布了新的文献求助10
5分钟前
星辰大海应助精明晓刚采纳,获得10
5分钟前
Joeswith完成签到,获得积分10
5分钟前
优美的明辉完成签到 ,获得积分10
5分钟前
帅气的沧海完成签到 ,获得积分10
6分钟前
jlwang完成签到,获得积分10
6分钟前
6分钟前
彦嘉发布了新的文献求助10
6分钟前
宇文雨文完成签到 ,获得积分10
6分钟前
6分钟前
末末完成签到 ,获得积分10
7分钟前
7分钟前
高分求助中
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3990568
求助须知:如何正确求助?哪些是违规求助? 3532220
关于积分的说明 11256532
捐赠科研通 3271057
什么是DOI,文献DOI怎么找? 1805207
邀请新用户注册赠送积分活动 882302
科研通“疑难数据库(出版商)”最低求助积分说明 809234